Sonia Del Barco Berrón

6PUBLICATIONS
60CO-AUTHORS
Medical biochemistry - carbohydratesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMajor global burdens of diseasePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 13, 2026
Anthropometric Characteristics of Triple-Negative Breast Cancer Patients by Menopausal Status: Evidence from the Population-Based Multicentric Study-MCC-Spain.

Marina Muñoz-Pérez, Lorena Botella-Juan, Facundo Vitelli-Storelli

|Dec 12, 2025
Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer.

Miguel Martín, Ángel L Guerrero-Zotano, María E Pérez-López

|Dec 04, 2025
Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.

María Ángeles Vaz-Salgado, Sonia Del Barco, Juan Manuel Sepúlveda

|Apr 28, 2025
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA Trial.

Antonio Llombart-Cussac, Catherine Harper-Wynne, Antonia Perelló

|Jan 10, 2025
Strategies to enhance management of HER2-positive breast cancer in the elderly: an expert consensus perspective.

Sonia Del Barco, Almudena Cotes-Sanchís, Mercedes Cavanagh

|Dec 04, 2018
Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients.

B Losada, J A Guerra, D Malón

Pageof 1

Frequent Collaborators

2 joint publications

Manuel Ruiz-Borrego

1 joint publications

B Losada

1 joint publications

María Ángeles Vaz-Salgado

1 joint publications

Carmen Balana